Pathophysiology of Tumor-Associated Macrophages

Advances in Clinical Chemistry

Volumn 45, Issue SUPPL.: COMPLETE, 2008, Pages 199-223

  Yuan, Ang ^a   Chen, Jeremy J W ^b,c   Yang, Pan Chyr ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MACROPHAGE; NEOPLASM; PATHOLOGY; REVIEW; STROMA CELL;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOTHERAPY; MACROPHAGES; NEOPLASMS; STROMAL CELLS;

EID: 38649105802     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2423(07)00008-X     Document Type: Review

References (126)

1. Tuxhorn J., Ayala G., and Rowley D. Reactive stroma in prostate cancer progression. J Urol 166 (2001) 2472-2483
2. Gupta R., and Dubois R. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1 (2001) 11-21
3. Kelly C., Keates S., Siegenberg D., Linevsky J., Pothoulakis C., and Brady H. IL-8 secretion and neutrophil activation by HT-29 colonic epithelial cells. Am J Physiol 267 (1994) G991-G997
4. Connolly D., Stoddard B., Harakas N., and Feder J. Human fibroblast-derived growth factor is a mitogen and chemoattractant for endothelial cells. Biochim Biophys Acta 144 (1987) 705-712
5. Fukumura D., Xavier R., Sugiura T., Chen Y., Park E., and Lu N. Tumor induction of VEGF promoter activity in stromal cells. Cell 94 (1998) 715-725
6. Leek R., Lewis C., Whitehouse R., Greenall M., Clarke J., and Harris A. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56 (1996) 4625-4629
7. Etoh T., Shibuta K., Barnard G., Kitano S., and Mori M. Angiogenin expression in human colorectal cancer: The role of focal macrophage infiltration. Clin Cancer Res 6 (2000) 3545-3551
8. Arenberg D., Keane M., DiGiovine B., Kunkel S., Strom S., Burdick M., et al. Macrophage infiltration in human non-small-cell lung cancer: The role of CC chemokines. Cancer Immunol Immunother 49 (2000) 63-70
9. Volodko N., Reiner A., Rudas M., and Jakesz R. Tumour-associated macrophages in breast cancer and their prognostic correlations. Breast 7 (1998) 99-105
10. Lissbrant I., Stattin P., Wikstrom P., Damber P., Egevad J., and Bergh A. Tumor associated macrophages in human prostate cancer: Relation to clinicopathological variables and survival. Int J Oncol 17 (2000) 445-451
11. Salvesen H., and Aksleen L. Significance of tumor-associated macrophages, vascular endothelial growth factor and thrombospodin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas. Int J Cancer 84 (1999) 539-543
12. Lee A., Happerfield L., Bobrow L., and Millis R. Angiogenesis and inflammation in invasive carcinoma of the breast. J Clin Pathol 50 (1997) 669-673
13. Hanada T., Nakagawa M., Emoto A., Nomura T., Nasu N., and Nomura Y. Prognostic value of tumour-associated macrophage count in human bladder cancer. Int J Urol 7 (2000) 263-269
14. Nishie A., Ono M., Shono T., Fukushi J., Otsubo M., Onoue H., et al. Macrophage infiltration and hemeoxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 5 (1999) 1107-1113
15. Shimura S., Yang G., Ebara S., Wheeler T., Frolov A., and Thompson T. Reduced infiltration of tumour-associated macrophages in human prostate cancer: Association with cancer progression. Cancer Res 60 (2000) 5857-5861
16. Chen J., Lin Y., Yao P., Yuan A., Chen H., Shun C., et al. Tumor-associated macrophages: The double-edged sword in cancer progression. J Clin Oncol 23 (2005) 1-12
17. Koukourakis M., Giatromanolaki A., Kakolyris S., O'Byrne K., Apostolikas N., Skarlatos J., et al. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: Impact on tumour neo-angiogenesis and survival. Br J Cancer 77 (1998) 1696-1703
18. Orre M., and Rogers P. Macrophages and microvessel density in tumors of the ovary. Gynecol Oncol 73 (1999) 47-50
19. Leek R., Landers R., Harris A., and Lewis C. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 79 (1999) 991-995
20. Hashimoto I., Kodama J., Seki N., Hongo A., Miyagi Y., Yoshinouchi M., et al. Macrophage infiltration and angiogenesis in endometrial cancer. Anticancer Res 20 (2000) 4853-4856
21. Tsutsui S., Yaduda K., Suzuki K., Tahara K., Higashi H., and Era S. Macrophage infiltration and its prognostic implications in breast cancer: The relationship with VEGF expression and microvessel density. Oncol Rep 14 (2005) 425-431
22. Takanami I., Takeuchi K., and Kodaira S. Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: Association with angiogenesis and poor prognosis. Oncology 57 (1999) 138-142
23. Koch A., Polverini P., Kunkel S., Harlow L., DiPietro L., Elner V., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258 (1992) 1798-1801
24. Pusztai L., Clover L., Cooper K., Starkey P., Lewis C., and McGee J. Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast. Br J Cancer 70 (1994) 289-292
25. Xiong M., Elson G., Legarda D., and Leibovich S. Production of vascular endothelial growth factor by murine macrophages. Am J Pathol 153 (1998) 587-598
26. Talks K., Turley H., Gatter K., Maxwell P., Pugh C., Ratcliffe P., et al. The expression and distribution of the hypoxia-inducible factors HIF-1 and HIF-2 in normal human tissues, cancers and tumor-associated macrophages. Am J Pathol 157 (2000) 411-421
27. Goede V., Brogelli L., Ziche M., and Augustin H. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 82 (1999) 765-770
28. Fujimoto J., Sakaguchi H., Aoki I., and Tamaya T. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res 60 (2000) 2632-2635
29. Makitie T., Summanen P., Tarkkanen A., and Kivela T. Tumor-infiltrating macrophages (CD68 + cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci 42 (2001) 1414-1421
30. Orre M., and Rogers P. Macrophages and microvessel density in tumors of the ovary. Gynecol Oncol 73 (1999) 47-50
31. Rossi M., Jones N., Candy E., Nicoll J., Compton J., Hughes J., et al. The mononuclear cell infiltrate compared with survival in high-grade astrocytomas. Acta Neuropathol 78 (1999) 189-193
32. White E., Strom S., Wys N., and Arenberg D. Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity. J Immunol 166 (2001) 7549-7555
33. Ueno T., Toi M., Saji H., Muta M., Bando H., Kuroi K., et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6 (2000) 3282-3289
34. Al-Sarireh B., and Eremin O. Tumor-associated macrophages (TAMs): Disordered function, immune suppression and progressive tumor growth. J R Coll Surg Edinb 45 (2000) 1-16
35. Semeraro N., Montemurro P., Conese M., Giordano D., Stella M., Restaino A., et al. Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies. Int J Cancer 45 (1990) 251-254
36. Sunderkotter C., Steinbrink K., Goebeler M., Bhardwaj R., and Sorg C. Macrophages and angiogenesis. J Leukoc Biol 55 (1994) 410-422
37. van-Netten J., Ashmead B., Parker R., Thornton I., Fletcher C., Cavers D., et al. Macrophage-tumor cell associations: A factor in metastasis of breast cancer?. J Leukoc Biol 54 (1993) 360-362
38. Mussoni L., Riganti M., Acero R., Erroi A., Conforti G., Mantovani A., et al. Macrophages associated with murine tumours express plasminogen activator activity. Int J Cancer 41 (1988) 227-230
39. Xu Y., Hagege J., Doublet J., Callard P., Sraer J., Ronne E., et al. Endothelial and macrophage upregulation of urokinase receptor expression in human renal cell carcinoma. Hum Pathol 28 (1997) 206-213
40. Hildenbrand R., Wolf G., Bohme B., Bleyl U., and Steinborn A. Urokinase plasminogen activator receptor (CD87) expression of tumor-associated macrophages in ductal carcinoma in situ, breast cancer, and resident macrophages of normal breast tissue. J Leukoc Biol 66 (1999) 40-49
41. Hildenbrand R., Dilger I., Horlin A., and Stutte H. Urokinase and macrophages in tumour angiogenesis. Br J Cancer 72 (1995) 818-823
42. Davies B., Miles D., Happerfield L., Naylor M., Bobrow L., Rubens R., et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67 (1993) 1126-1131
43. Davies B., Waxman J., Wasan H., Abel P., Williams G., Krausz T., et al. Levels of matrixmetalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53 (1993) 5365-5369
44. Naylor M., Stamp G., Davies B., and Balkwill F. Expression and activity of MMPS and their regulators in ovarian cancer. Int J Cancer 58 (1994) 50-56
45. Quinn J., McGee J., and Athanasou N. Human tumour associated macrophages differentiate into osteoclastic bone resorbing cells. J Pathol 184 (1998) 31-36
46. Young M., Wright M., Coogan M., Young M., and Bagash J. Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor beta. Cancer Immunol Immunother 35 (1992) 14-18
47. Metzger Z., Hoffeld J., and Oppenheim J. Macrophage-mediated suppression. I. Evidence for participation of both hydrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J Immunol 124 (1980) 983-988
48. Akdis C., and Blaser K. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: Two key steps in specific immunotherapy. FASEB J 13 (1999) 603-609
49. Shih J., Yuan A., Chen J., and Yang P. Tumor-associated macrophage: Its role in cancer invasion and metastasis. J Cancer Mol 2 (2006) 101-105
50. Migita T., Sato E., Saito K., Mizoi T., Shiiba K., Matsuno S., et al. Differing expression of MMPs-1 and 9 and urokinase receptor between diffuse and intestinal type gastric carcinoma. Int J Cancer 84 (1999) 74-79
51. Kerr K., Johnson S., King G., Kennedy M., Weir J., and Jeffrey R. Partial regression in primary carcinoma of the lung: Does it occur?. Histopathology 33 (1998) 55-63
52. Funada Y., Noguchi T., Kikuchi R., Takeno S., Uchida Y., and Gabbert H. Prognostic significance of CD8 + T cell and macrophage peritumoral infiltration in colorectal cancer. Oncol Rep 10 (2003) 309-313
53. Welsh T., Green R., Richardson D., Waller D., O'Byrne K., and Bradding P. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol 23 (2005) 8959-8967
54. Ohno S., Inagawa H., Dhar D., Fujii T., Ueda S., Tachibana M., et al. The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Anticancer Res 23 (2003) 5015-5022
55. Mantovani A. Tumor-associated macrophages in neoplastic progression: A paradigm for the in vivo function of chemokines. Lab Invest 71 1 (1994) 5-16
56. Tartour E., and Fridman W. Cytokines and cancer. Int Rev Immunol 16 (1998) 683-704
57. Bonta I., Ben-Efraim S., Mozes T., and Fieren M. Tumour necrosis factor in inflammation: Relation to other mediators and to macrophage antitumour defence. Pharmacol Res 24 (1991) 115-130
58. Martin J., and Edwards S. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J Immunol 150 (1993) 3478-3486
59. Albina J., and Reichner J. Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev 17 (1998) 39-53
60. Chambers V., and Weiser R. The ultrastructure of sarcoma I cells and immune macrophages during their interaction in the peritoneal cavities of immune C57BL-6 mice. Cancer Res 32 (1972) 413-419
61. Dingemans K., Pels E., and Den-Otter W. Destruction of murine lymphoma cells by allogeneic immune peritoneal macrophages in vitro: An ultrastructure study. J Nat Cancer Inst 66 (1981) 67-79
62. Cui S., Reichner J., Mateo R., and Albina J. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res 54 (1994) 2462-2467
63. Onodera S., Suzuki K., Matsuno T., Kaneda K., Takagi M., and Nishihira J. Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology 92 (1997) 131-137
64. Pozzi L., and Weiser W. Human recombinant migration inhibitory factor activates human macrophages to kill tumour cells. Cell Immunol 145 (1992) 372-379
65. Kamimura A., Kamachi M., Nishihira J., Ogura S., Isobe H., Dosaka-Akita H., et al. Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung. Cancer 89 (2000) 334-341
66. Shinohara H., Yano S., Bucana C., and Fidler I. Induction of chemokine secretion and enhancement of contact-dependent macrophage cytotoxicity by engineered expression of granulocyte-macrophage colony-stimulating factor in human colon cancer cells. J Immunol 164 (2000) 2728-2737
67. Narvaiza I., Mazzolini G., Barajas M., Duarte M., Zaratiegui M., Qian C., et al. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy. J Immunol 164 (2000) 3112-3122
68. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25 (2004) 677-686
69. Coussens L., and Werb Z. Inflammation and cancer. Nature 420 (2000) 860-867
70. Leek R., Hunt N., Landers R., Lewis C., Royds J., and Harris A. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 190 (2000) 430-436
71. Ono M., Toris H., Fukushi J., Nishie A., and Kuwano M. Biological implications of macrophage infiltration in human tumor angiogenesis. Cancer Chemother Pharmacol 43 (1999) S69-S71
72. Vacca A., Ribatti D., Ruco L., Giacchetta F., Nico B., Quondamatteo F., et al. Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Br J Cancer 79 (1999) 965-970
73. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 333 (1995) 1757-1763
74. Folkman J., and Sning Y. Angiogenesis. J Biol Chem 267 (1992) 10931-10934
75. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147 (1995) 9-19
76. Weidner N., Semple J., Welch W., and Folkman J. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 324 (1991) 1-8
77. Macchiarini P., Gonatanini G., Hardin M., Squartini F., and Angiletti G. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet, 340 (1992) 145-146
78. Fidler I., and Ellis L. The implication of angiogenesis for the biology and therapy of cancer metastasis. Cell 79 (1994) 185-188
79. Hanahan D., and Folkman J. Patterns and merging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
80. Friesel R., and Maciag T. Molecular mechanisms of angiogenesis: Fibroblast growth factor signal. FASEB J 9 (1995) 919-925
81. Olofsson B., Pajusola K., Kaipainen A., von Euler G., Joukov V., Saksela O., et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 93 (1996) 2576-2581
82. Chen J., Yao P., Yuan A., Hong T., Shun C., Kuo M., et al. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: Its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res 9 (2003) 729-737
83. Liss C., Fekete M., Hasina R., Lam C., and Lingen M. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int J Cancer 93 (2001) 781-785
84. Torisu H., Ono M., Kiryu H., Furue M., Ohmoto Y., Nakayama J., et al. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNF-alpha and IL-1-alpha. Int J Cancer 85 (2000) 182-188
85. Yao P., Lin Y., Wang C., Huang Y., Liao W., Wang S., et al. Autocrine and paracrine regulation of IL-8 expression in lung cancer cells. Am J Respir Cell Mol Biol 32 (2005) 540-547
86. Yoshida S., Ono M., Shono T., Izumi H., Ishibashi T., Suzuki H., et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 17 (1997) 4015-4023
87. Anderson I., Mari S., Broderick R., Mari B., and Shipp M. The angiogenic factor interleukin 8 is induced in non-small cell lung cancer/pulmonary fibroblast cocultures. Cancer Res 60 (2000) 269-272
88. Hoffmann E., Dittrich-Breiholz O., Holtmann H., and Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol 72 (2000) 847-855
89. Kalluri R., and Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 6 5 (2006) 392-401
90. Chen J., Wu R., Yang P., Huang J., Sher Y., Han M., et al. Profiling expression patterns and isolating differentially expressed genes by cDNA microarray system with colorimetry detection. Genomics 51 (1998) 313-324
91. Salgado R., Junius S., Benoy I., Van Dam P., Vermeulen P., Van Marck E., et al. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer 103 (2003) 642-646
92. Montuori N., Mattiello A., Mancini A., Taglialatela P., Caputi M., Rossi G., et al. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non-small cell lung carcinoma. Int J Cancer 105 (2003) 353-360
93. Wascher R., Huynh K., Giuliano A., Hansen N., Singer F., Elashoff D., et al. Stanniocalcin-1: A novel molecular blood and bone marrow marker for human breast cancer. Clin Cancer Res 9 (2003) 1427-1435
94. Dosquet C., Coudert M., Lepage E., Cabane J., and Richard F. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?. Clin Cancer Res 3 (1997) 2451-2458
95. Shiozawa J., Ito M., Nakayama T., Nakashima M., Kohno S., and Sekine I. Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod Pathol 13 (2000) 925-933
96. Baltathakis I., Alcantara O., and Boldt D. Expression of different NF-κB pathway genes in dendritic cells (DCs) or macrophages assessed by gene expression profiling. J Cell Biochem 83 (2001) 281-290
97. Kelly R., King A., and Critchley H. Cytokine control in human endometrium. Reproduction 121 (2001) 3-19
98. Giovannucci E., Egan K., Hunter D., Stampfer M., Colditz G., Willett W., et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 333 (1995) 609-614
99. Harris R., Namboodiri K., and Farrar W. Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 7 (1996) 203-205
100. Keifer J., Guttridge D., Ashburner B., and Baldwin Jr. A. Inhibition of NF-kB activity by thalidomide through suppression of IkB kinase activity. J Biol Chem 276 (2001) 22382-22387
101. Liu S., Ye X., and Malik A. Inhibition of NFκB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation 100 (1999) 1330-1337
102. Yoo C., Lee S., Lee C., Kim Y., Han S., and Shim Y. Effect of acetylsalicylic acid on endogenous IκB kinase activity in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 280 (2001) L3-L9
103. Mukaida N., Morita M., Ishikawa Y., Rice N., Okamoto S., Kasahara T., et al. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 269 (1994) 13289-13295
104. Chang M., Juarez M., Hyde D., and Wu R. Mechanism of dexamethasone-mediated interleukin-8 gene suppression in cultured airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 280 (2001) L107-L115
105. Hsu A., Ching T., Wang D., Song X., Rangnekar V., Chen C., et al. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 275 (2000) 11397-11403
106. Dirkx A., Egbrink G., Wagstaff J., and Griffioen A. Monocyte/macrophage infiltration in tumors: Modulators of angiogenesis. J Leukoc Biol 80 (2006) 1183-1196
107. Bingle L., Brown N., and Lewis C. The role of tumor-associated macrophages in tumor progression: Implications for new anticancer therapies. J Pathol 196 (2002) 254-265
108. Wahl L., and Kleinman H. Tumor-associated macrophages as targets for cancer therapy. J Natl Cancer Inst 90 (1998) 1583-1584
109. Klimp A., de Vreies E., Scherphof G., and Daemen T. A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol 44 (2002) 143-161
110. Asano T., and Kleinerman E. Liposome-encapsulated MTP-PE: A novel biologic agent for cancer therapy. J Immunother 14 (1993) 286-292
111. Nagler A., Shur I., Barak V., and Fabian I. Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation. Leuk Res 20 (1996) 637-643
112. Andreesen R., Scheibenbogen C., Brugger W., Krause S., Meerpohl H., Leser H., et al. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: A new approach to cancer immunotherapy. Cancer Res 50 (1990) 7450-7456
113. Hennemann B., Scheibenbogen C., and Andreesen R. Biological response to intrahepatic adoptive immunotherapy with autologous interferon activated macrophages. Eur J Cancer 31A (1995) 852
114. Faradji A., Bohbot A., Frost H., Schmitt-Goguel M., Siffert J., Dufour P., et al. Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis. J Clin Oncol 9 (1991) 1251-1260
115. Dranoff G., Jaffee E., Lazenby A., Golumbek P., Levitsky H., Brose K., et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte macrophage colony- stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90 (1993) 3539-3543
116. Sanda M., Ayyagari S., Jaffee E., Epstein J., Clift S., Cohen L., et al. Demonstration of a rational strategy for human prostate cancer gene therapy. J Urol 151 (1994) 622-628
117. Morita T., Ikeda K., Douzono M., Yamada M., Kimura F., Kawakami K., et al. Tumor vaccination with macrophage colony-stimulating factor-producing Lewis lung carcinoma in mice. Blood 88 (1996) 955-961
118. Dong Z., Greene G., Pettaway C., Dinney C., Eue I., Lu W., et al. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta. Cancer Res 59 (1999) 872-879
119. Soiffer R., Lynch T., Mihm M., Jung K., Rhuda C., Schmollinger J., et al. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci USA 95 (1998) 13141-13146
120. Simons J., Jaffee E., Weber C., Levitsky H., Nelson W., Carducci M., et al. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte- macrophage colony-stimulating factor gene transfer. Cancer Res 57 (1997) 1537-1546
121. Nabel G., Gordon D., Bishop D., Nickoloff B., Yang Z., Aruga A., et al. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. Proc Natl Acad Sci USA 93 (1996) 15388-15393
122. Mahvi D., Sondel P., Yang N., Albertini M., Schiller J., Hank J., et al. Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma. Hum Gene Ther 8 (1997) 875-891
123. Lei H., Ju D., Yu Y., Tao Q., Chen G., Gu S., et al. Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factor and interferon-gamma. Gene Ther 7 (2000) 707-713
124. Bartholeyns J., and Lopez M. Immune control of neoplasia by adoptive transfer of macrophages: Potentiality for antigen presentation and gene transfer. Anticancer Res 14 (1994) 2673-2676
125. Huang S., Xie K., Bucana C., Ullrich S., and Bar-Eli M. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: Potential inhibition of angiogenesis. Clin Cancer Res 2 (1996) 1969-1979
126. Griffiths L., Binley K., Iqball S., Kan O., Maxwell P., Ratcliffe P., et al. The macrophage-a novel system to deliver gene therapy to pathological hypoxia. Gene Ther 7 (2000) 255-262